Antonelli Incalzi, Raffaele
De Vincentis, Antonio
Li, Vicky W.
Martin, Ashley
Di Laura, Danilo
Fonseca, Eileen
Ding, Helen
Funding for this research was provided by:
Merck
Article History
Received: 12 March 2024
Accepted: 9 June 2024
First Online: 20 June 2024
Declarations
:
: All study respondents underwent informed consent, and respondent information was fully anonymized. The study (protocol, 19-KANT-205) received an exempt status upon evaluation by the Pearl Institutional Review Board.
: Not applicable.
: Raffaele Antonelli Incalzi and Antonio De Vincentis have no conflicts of interest to report. Vicky W. Li is an employee of Oracle Life Sciences, Seattle, WA, USA. Ashley Martin was an employee of Oracle Life Sciences, Seattle, WA, USA at the time of this work. Danilo Di Laura is an employee of MSD Italia. Eileen Fonseca and Helen Ding are employees of Merck Sharp & LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and shareholders in Merck & Co., Inc., Rahway, NJ, USA.